tiprankstipranks
Trending News
More News >
NervGen Pharma (TSE:NGEN)
:NGEN
Canadian Market

NervGen Pharma (NGEN) Income Statement

Compare
57 Followers

NervGen Pharma Income Statement

Last quarter (Q3 2025), NervGen Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, NervGen Pharma's net income was C$-4.16M. See NervGen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -83.80KC$ -145.00KC$ -115.11KC$ -42.63KC$ -39.65K
Operating Expenses
C$ 24.85MC$ 17.63MC$ 23.03MC$ 12.81MC$ 11.20M
Depreciation and Amortization
C$ 83.80KC$ 145.00KC$ 115.11KC$ 42.63KC$ 39.65K
EBITDA
C$ -23.92MC$ -17.63MC$ -20.09MC$ -12.77MC$ -11.16M
Operating Income
C$ -24.93MC$ -17.78MC$ -22.82MC$ -12.87MC$ -11.19M
Other Income/Expenses
C$ 926.10KC$ -4.61MC$ 2.30MC$ 84.65KC$ 9.74K
Pretax Income
C$ -24.01MC$ -22.38MC$ -20.72MC$ -12.73MC$ -11.19M
Net Income
C$ -24.01MC$ -22.38MC$ -18.11MC$ -12.64MC$ -11.18M
Per Share Metrics
Basic EPS
C$ -0.36C$ -0.38C$ -0.34C$ -0.32C$ -0.35
Diluted EPS
C$ -0.36C$ -0.38C$ -0.34C$ -0.32C$ -0.35
Weighted Average Shares Outstanding
67.32M 59.29M 52.65M 39.29M 32.11M
Weighted Average Shares Outstanding (Diluted)
67.32M 59.29M 52.65M 39.29M 32.11M
Currency in CAD

NervGen Pharma Earnings and Revenue History